Skip to main content

Table 1 Summary of the demographic, clinical and neuroimaging information of the study subjects

From: Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families

Patient ref no.

Family 66

Family 97

66-E

66-K

66-L

97-E

Gender/AAE (y)

Female/35

Male/28

Male/31

Female/30

AAO (y)

26

22

23

25

Initial symptoms

Depression/bradykinesia

Depression/tremor

Bradykinesia

Neuropsychiatric symptoms

Bradykinesia

+++

++

+++

++

Tremors

Yes

Yes

No

No

Postural instability

+++

++

+++

+++

Dystonia

No

No

No

No

Loss of ambulation

3 y after onset

ambulatory

3 y after onset

2 y after onset

Pyramidal signs

++

+

++

+

Cerebellar signs

No

No

No

No

Levodopa response

Yes -minimal

Yes -minimal

Yes -minimal

Yes -moderate

Levodopa-induced dyskinesia

++

–

++

–

Frontotemporal atrophy on MRI

++

+

++

++

Iron accumulation

No

No

No

No

PET scan

Frontotemporal lobe

Frontotemporal lobe

Not done

Frontotemporal lobe

Hoehn & Yahr stage

4.5

4

5

4

Neuropsychiatric symptoms

++

++

+

+++

Emotional Liability

+++

+

+

+++

Cognitive decline

+

++

+

+

Semantic disorder

+

+

+

–

Autonomic symptoms

Yes

Yes

Yes

No

 Bladder disturbances

Urgency

Urge incontinence

Urgency

–

 Sweating

Yes

Yes

No

–

 Flushing

No

Yes

No

–

Sleep disorders

Yes

Yes

Yes

Yes

 REM-sleep behavior disorder

Yes

No

No

–

 Vivid dreaming

No

Yes

No

Yes

 Sleep fragmentation

Yes

Yes

Yes

–

Death

Alive

Alive

Died after 8 y

Alive

  1. AAE age at examination; y years; AAO age at onset; REM rapid eye movement; + mild; ++ moderate; +++ severe